Ying Song joined Ropes & Gray in 2014 as a technical advisor in the Intellectual Property group. Prior to joining the firm, Ying was a postdoctoral associate at MIT. Her research focused on developing novel platinum-based anticancer agents and studying their mechanism of action. Ying obtained her Ph.D. from Northwestern University where she developed magnetic resonance contrast agents for cell labeling and intracellular calcium signaling.
- Co-author “Synthesis and Characterization of Pt(IV) Fluorescein Conjugates to Investigate Pt(IV) Intracellular Transformation,” ChemComm. (2014)
- Co-author “Phenanthriplatin, a Monofunctional, DNA-Binding Platinum Anticancer Drug Candidate with Unusual Potency and Cellular Activity Profile.” Proc. Natl. Acad. Soc. (2012)
- Co-author “Multimodal Optical/MR Contrast Agents Based on Porphyrazines for Potential Cell Imaging,” Bioconjugate Chem, (2010)
- Co-author “Multimodal Gd-enriched DNA Gold Nanoparticle Conjugates for Cellular Imaging,” Angew. Chem. (2009)
- Co-author “Synthesis and Characterization of Multimeric Contrast Agents for Cell MR Imaging,” J. Am. Chem. Soc. (2008)
- Co-author “Modification of Embolic-PVA Particles with MR Contrast Agents,” Mag. Reson. Med. (2008)